Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

David Warrell, MORU founding director, has been appointed by the Queen ‘Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice’. Please join us in congratulating Sir David on receiving this richly deserved high honour!

David Warrell

Professor Sir David Warrell and his wife Mary came to Thailand in 1979 to work with the Faculty of Tropical Medicine, setting up what was then called the ‘Wellcome Unit’. It was his vision and ground-breaking research work that set the tone and direction for the subsequent 40 years of collaborative research in the MORU Network, so all of us owe him an enormous debt of gratitude.

Sir David left Thailand in 1986, and since then he has worked in Africa, Asia, Oceania and Latin America. His research interests over the years include malaria, respiratory diseases, relapsing fever, rabies, malaria, and venomous and poisonous plants and animals.

He published some of the earliest randomised controlled trials of antivenoms, in Nigeria, Thailand, Brazil, Ecuador, Colombia and Papua New Guinea, and was involved in the landmark 2005 “million death study” in India that revealed the enormous burden of snakebite in that country (46,000 deaths a year).

He has in particular continued to work hard to raise the profile of snakebite as an important environmental and occupational health hazard. This culminated in the recognition of snakebite as a category A neglected tropical disease (NTD) by WHO and approval of a resolution by the 2018 World Health Assembly to promote the control of this most neglected of all NTDs.

He has been senior editor of the Oxford Textbook of Medicine, Essential Malariology, and the Oxford Handbook of Expedition and Wilderness Medicine, and has co-authored more than 400 papers on various topics in tropical medicine.

He and Mary have always stayed in touch with the unit they founded, and were here in 2019 to join the MORU 40th anniversary festivities. We very much hope that they will join us here again soon so that we can celebrate David’s knighthood with him in person.

- Nick Day and Nick White.

Similar stories

Field evaluation of EasyScan GO: a digital malaria microscopy device

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.

Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications

OUCRU research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.

Registration is open for The Global Health Network Conference 2022

To tackle disease we need evidence to be generated through every type of health research study. This conference aims to bring together health research teams, organisations, health-workers, policy makers and practitioners to explore together how health research can be embedded into every healthcare setting. Join us at The Global Health Network Conference 2022 at the University of Cape Town, South Africa, 24 – 25 November 2022

The inside story of Recovery: how the world’s largest COVID-19 trial transformed treatment – and what it could do for other diseases

Two years ago, the Recovery trial transformed the care of COVID patients with its dexamethasone announcement. Within four hours, the steroid was included in NHS treatment recommendations. Almost overnight, treatment of COVID patients around the world changed completely. It has been estimated that dexamethasone may have saved a million lives in the first nine months following the announcement. Recovery is a groundbreaking scientific machine which, from the outset, moved at unprecedented speed. In the first 100 days alone, the trial produced three groundbreaking results that would completely reshape COVID care.

Gail Carson chair of GOARN

Dr Gail Carson from the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is nominated chair of WHO Global Outbreak Alert & Response Network (GOARN)

Enhanced vaccination against Japanese encephalitis virus could reduce encephalitis prevalence by one third in SE Asia

Encephalitis is a worldwide public health issue, with a substantially high burden among children in Southeast Asia. A large study of the causes of childhood encephalitis in SE Asia suggests that enhanced and effective vaccination against the Japanese encephalitis virus alone could reduce encephalitis prevalence by one third.